Kallyope

Enrolling, Weight Loss
The main purpose of this study is to assess the change in baseline in body weight after 13 weeks of treatment with K-757 alone and in…

Merck Cholesterol

Enrolling, Cholesterol
The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The…

Power HF

Enrolling, Heart Failure
The purpose of this study is to evaluate the efficacy of the medication JTT-861 administered for 12 weeks in subjects with heart failure…

Librexia

Enrolling, Atrial Fibrillation
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and…

Achieve-4-GZGS

Enrolling, Diabetes
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type…

Oceanic (a)

Enrolling, Lipoprotein (a)
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease…

Surmount-4

In Follow Up, Weight Loss
This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains…

Alpaca

In Follow Up, Lipoprotein (a)
The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a). The study will…

Surmount-MMO

Enrolling, Weight Loss
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide…

Oceanic-AF

Enrolling, Atrial Fibrillation
Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots…

Azalea A Fib

In Follow Up
The purpose of the ANT-006 study is to evaluate the bleeding profile of abelacimab relative to rivaroxaban in patients with atrial…

Embrace UTI

Enrolling
The purpose of this study is to demonstrate the efficacy of 9-valent extraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared…
Capital Area Research LLC © Copyright 2023 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389